Zoetis (ZTS) Change in Account Payables (2014 - 2026)
Zoetis (ZTS) posted quarterly Change in Account Payables of $62.0 million for Q1 2026, up 181.82% year-over-year from $22.0 million in Q1 2025, and down 18.42% quarter-over-quarter from $76.0 million in Q4 2025.
Zoetis (ZTS) Change in Account Payables (2014 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Change in Account Payables for 13 consecutive years, with $62.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Account Payables rose 181.82% year-over-year to $62.0 million; the TTM figure through Mar 2026 stood at $86.0 million (up 53.57% YoY), while the FY2025 annual figure was $46.0 million, up 48.39% from the prior year.
- Change in Account Payables slipped to $62.0 million in Q1 2026 per ZTS's latest filing, from $76.0 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $76.0 million in Q4 2025 and bottomed at -$74.0 million in Q3 2023.
- Historically, Change in Account Payables has averaged $7.2 million across 5 years, with a median of $22.0 million in 2023.
- Annual changes were most pronounced in 2022 — Change in Account Payables slumped 365.0% — and 2025, when it soared 833.33%.
- Zoetis' Change in Account Payables stood at $30.0 million in 2022, then fell by 26.67% to $22.0 million in 2023, then grew by 18.18% to $26.0 million in 2024, then surged by 192.31% to $76.0 million in 2025, then slipped by 18.42% to $62.0 million in 2026.
- Business Quant data shows ZTS's Change in Account Payables at $62.0 million in Q1 2026, $76.0 million in Q4 2025, and -$54.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | -53.00 Mn |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | -143.74 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -21.20 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | - |
| 10 | Alkermes | 8.17 Bn | 7.51 Bn | 397.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -53.00 Mn |
| Jun 30, 2026 | -53.00 Mn |
| Mar 31, 2026 | 62.00 Mn |
| Mar 31, 2026 | 62.00 Mn |
| Dec 31, 2025 | 76.00 Mn |
| Dec 31, 2025 | 76.00 Mn |
| Sep 30, 2025 | -54.00 Mn |
| Sep 30, 2025 | -54.00 Mn |
| Jun 30, 2025 | 2.00 Mn |
| Jun 30, 2025 | 2.00 Mn |
| Mar 31, 2025 | 22.00 Mn |
| Mar 31, 2025 | 22.00 Mn |
| Dec 31, 2024 | 26.00 Mn |
| Dec 31, 2024 | 26.00 Mn |
| Sep 30, 2024 | -15.00 Mn |
| Sep 30, 2024 | -15.00 Mn |
| Jun 30, 2024 | 23.00 Mn |
| Jun 30, 2024 | 23.00 Mn |
| Mar 31, 2024 | -3.00 Mn |
| Mar 31, 2024 | -3.00 Mn |